Skip to main content

Table 1 Clinical characteristics of the study groups

From: Impact of acute total occlusion of the culprit artery on outcome in NSTEMI based on the results of a large national registry

 

NSTEMINTO (N = 65,206)

NSTEMITO (N = 16,209)

STEMITO (N = 50,314)

Age (years), mean (SD)

68.78 (11.39)

65.98 (11.61)

64.86 (12.04)

Male sexa, n (%)

42.380 (65.19%)

11.215 (69.53%)*

34.133 (68.00%)

Weight (kg), mean (SD)

79.98 (17.49)

81.64 (17.54)

80.52 (16.67)

Smokers, n (%)

14.075 (21.59%)

4.303 (26.55%)

14.842 (29.50%)

Arterial hypertension, n (%)

47.872 (73.42%)

11.222 (69.23%)

29.912 (59.45%)

Diabetes, n (%)

17.774 (27.26%)

3.737 (23.06%)

8.729 (17.35%)

Kidney disease, n (%)

5.633 (8.64%)

948 (5.85%)

1.647 (3.27%)

COPDb, n (%)

1.718 (3.61%)

343 (2.90%)$

659 (1.75%)

Previous stroke, n (%)

2.877 (4.41%)

671 (4.14%)#

1.687 (3.35%)

Previous PCI, n (%)

17.433 (26.74%)

3.027 (18.67%)

6.010 (11.94%)

Previous CABG, n (%)

4.300 (6.59%)

835 (5.15%)

814 (1.62%)

Previous MI, n (%)

18.406 (28.23%)

3.550 (21.90%)

6.493 (12.90%)

Killip class IIIc, n (%)

1.051 (2.25%)

325 (2.47%)

1.431 (3.33%)

Killip class IVc, n (%)

787 (1.69%)

326 (2.48%)

2.162 (5.03%)

Cardiac arrest before admissiond, n (%)

1.208 (2.19%)

477 (3.09%)

2.962 (6.02%)

Cardiac arrest during angiographyd, n (%)

151 (0.27%)

82 (0.53%)

19 (0.04%)

  1. p < 0.0001 for all analyses of the study groups by Kruskal–Wallis one-way analysis of variance
  2. Data are presented as the mean and standard deviation (SD) or number (n) and percentage (%)
  3. NSTEMINTO: non-ST-segment elevation myocardial infarction without total occlusion of the culprit artery; NSTEMITO: non-ST-segment elevation myocardial infarction with total occlusion of the culprit artery; STEMITO: ST-segment elevation myocardial infarction with total occlusion of the culprit artery; COPD: chronic obstructive pulmonary disease; PCI: percutaneous coronary intervention; CABG: coronary artery bypass graft; MI: myocardial infarction
  4. p < 0.0001 for all post hoc analyses with the following exceptions:
  5. *p = 0.0003 for post hoc comparison between NSTEMITO and STEMITO;
  6. $p = 0.0002 for post hoc comparison between NSTEMINTO and NSTEMITO;
  7. #p = 0.1283 for post hoc comparison between NSTEMINTO and NSTEMITO
  8. Data available for a – 131,452 patients, b – 96,952 patients, c – 102,807 patients, d – 119,955 patients